Download Citation
Article Source:
Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion
Sun H,
Jiang Y,
Lan M,
Zhou M,
Yi G,
et al.
(2025)
Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion.
PLOS Pathogens 21(12): e1013744.
https://doi.org/10.1371/journal.ppat.1013744